About Mauna Kea Technologies

Mauna Kea Technologies is a medical device company based in Paris, France. With its flagship Cellvizio system, the company leads the growing endomicroscopy imaging market, enabling physicians to visualize, diagnose and treat directly inside the body pathologies that cannot be seen using other imaging techniques. Investors include Psilos Group, Seventure and Creadev. For more information about Mauna Kea Technologies visit www.maunakeatech.com


About EndoControl

EndoControl is an innovative company which specializes in the development of robotic surgical solutions for endoscopic surgery, where it markets a range of products including ViKY, a multi task, compact robotic assistant for laparoscopic, pelviscopic and thoracoscopic surgery which easily integrates in the operating room. Since it received CE marking in 2007 and FDA approval in 2008, over 1,000 surgical procedures have been performed with ViKY.EndoControl has established an international distribution network that utilizes independent specialized distributor partners. EndoControl has installed over 35 systems worldwide, with installations in Austria, Germany, Belgium, France, Italy, Spain, Holland, the U.K, the US and Canada. EndoControl has also developed clinical relationships with many renowned clinicians and institutions in laparoscopic surgery (Institut Mutualiste Montsouris, Paris; Cleveland Clinic, USA; Fox Chase Cancer Center, Philadelphia, USA; Fundacion Puigvert, Barcelona, Spain). Through these relationships EndoControl has been able to transfer its
unique expertise in surgical robotic systems technology from research
laboratories directly into the operating room.Founded in 2006 by Clement VIDAL and Patrick HENRI, the company is based in La Tronche, near Grenoble, in the business incubator Biopolis and has 12 employees.For more information about EndoControl, visit www.endocontrol.fr

About IMM

Institut Mutualiste Montsouris is a private non profit hospital, located south of Paris, affiliated to University Paris Descartes. Organized into medico-surgical departments, its activities cover a wide range of medical and surgical diseases, with highly specialized teams. Since 1989, with a world premiere in laparoscopic cholecystectomy, IMM has plaid a leading role in the development and the adoption of modern surgical techniques. Laparoscopy is now routinely chosen at IMM for all digestive organs, including liver and pancreas, where an unequalled average of 94% of hepatectomies are performed under laparoscopy. For

More HCB News